HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lynn Broughton Selected Research

human MV833 monoclonal antibody

3/2005Phase I investigation of recombinant anti-human vascular endothelial growth factor antibody in patients with advanced cancer.
10/2002Molecular imaging and biological evaluation of HuMV833 anti-VEGF antibody: implications for trial design of antiangiogenic antibodies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lynn Broughton Research Topics

Disease

2Neoplasms (Cancer)
03/2005 - 10/2002

Drug/Important Bio-Agent (IBA)

2human MV833 monoclonal antibodyIBA
03/2005 - 10/2002
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2005 - 10/2002
1Monoclonal AntibodiesIBA
03/2005
1Immunoglobulin G (IgG)IBA
03/2005
1Biological ProductsIBA
10/2002